This page is in verification process.
Buyers can use information for reference only. Freshdi is not responsible for information on this page.
If you own PAN ASIA Biomedical Technology, claim it to manage this profile and connect with international buyers.

Add Favorite

|

Report Supplier

|

Business Overview

Avg Response Time

≤ 1h

In biomedical supply chains, reliable communication and verified contact details are essential to build trust with buyers. PAN ASIA Biomedical Technology lacks verification on work email, phone, and business documents — this makes it harder for buyers to confirm the company's legitimacy or reach the right person directly. Without verified contact points, buyers may hesitate to place large orders or share sensitive technical requirements. While pipettes are a common lab product, the absence of verification increases the risk of fraud or miscommunication. Buyers should request additional proof, such as a company registration or a recent invoice, before engaging. This lack of verification is common among new or small suppliers, but it's a key red flag in high-stakes medical equipment trade.

Trade Capabilities

Business Terms

Preferred Payment Term:

Not specified

Preferred Trade Term:

Not specified

Port Of Loading:

Not specified

Accepted Currency:

USD

Trade Ability

Annual Revenue Amount:

Not specified

Numbers Of Employees:

Not specified

Avg Response Time:

-

Products / Services Offered

Own this company?

PAN ASIA Biomedical Technology
Unverified

Claim store, then activate and verify to showcase products.

Supplier sign-up – promo banner, free supplier page sidebar

Pipettes market insight

Across Tools, Instruments & Testing, the wider group Pipettes belongs to, Freshdi lists 8 active supply listings from 5 suppliers in 5 countries, as of 16 November 2026. Suppliers across Tools, Instruments & Testing, the wider group Pipettes belongs to, come from 5 countries, led by China at 20.0%, on Freshdi as of 16 November 2026. Buyer inquiry volume across Tools, Instruments & Testing, the wider group Pipettes belongs to, rose 166.7% on Freshdi in the 30 days to 16 November 2026 against the 30 days before, with 111.25% volatility in monthly inquiry and quotation activity over 344 days.